AMARIN CORP PLC\UK APIC, Share-based Payment Arrangement, Increase for Cost Recognition
AMARIN CORP PLC\UK (AMRN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-29
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.10M, a 65.23% decline year-over-year.
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.33M, a 46.13% decline year-over-year.
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.96M, a 58.37% decline year-over-year.
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $6.04M, a 37.66% increase year-over-year.
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $13.94M, a 21.28% decline from fiscal 2024.
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $17.70M, a 13.16% increase from fiscal 2023.
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $15.65M, a 40.31% decline from fiscal 2022.
- AMARIN CORP PLC\UK apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $26.21M, a 29.04% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.10M 10-Q · filed 2026-07-29 | $4.43M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $2.33M 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $13.94M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $1.96M 10-Q · filed 2025-10-29 | $8.00M derived: sum of 2 quarters · filed 2026-07-29 | $12.32M derived: sum of 3 quarters · filed 2026-07-29 | |
| 2025-06-30 | $6.04M 10-Q · filed 2026-07-29 | $10.37M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $4.33M 10-Q · filed 2026-07-29 | |||
| 2024-12-31 | $17.70M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $4.70M 10-Q · filed 2025-10-29 | $9.09M derived: sum of 2 quarters · filed 2025-10-29 | $14.30M derived: sum of 3 quarters · filed 2025-10-29 | |
| 2024-06-30 | $4.39M 10-Q · filed 2025-10-29 | $9.61M derived: sum of 2 quarters · filed 2025-10-29 | ||
| 2024-03-31 | $5.22M 10-Q · filed 2025-10-29 | |||
| 2023-12-31 | $15.65M 10-K · filed 2026-03-02 | |||
| 2023-09-30 | $3.61M 10-Q · filed 2024-10-30 | $5.44M derived: sum of 2 quarters · filed 2024-10-30 | $11.00M derived: sum of 3 quarters · filed 2024-10-30 | |
| 2023-06-30 | $1.83M 10-Q · filed 2024-10-30 | $7.39M derived: sum of 2 quarters · filed 2024-10-30 | ||
| 2023-03-31 | $5.56M 10-Q · filed 2024-10-30 | |||
| 2022-12-31 | $26.21M 10-K · filed 2024-02-29 | |||
| 2022-09-30 | $4.88M 10-Q · filed 2023-11-01 | $13.52M derived: sum of 2 quarters · filed 2023-11-01 | $19.60M derived: sum of 3 quarters · filed 2023-11-01 | |
| 2022-06-30 | $8.65M 10-Q · filed 2023-11-01 | $14.72M derived: sum of 2 quarters · filed 2023-11-01 | ||
| 2022-03-31 | $6.08M 10-Q · filed 2023-11-01 | |||
| 2021-12-31 | $36.94M 10-K · filed 2023-03-01 | |||
| 2021-09-30 | $10.43M 10-Q · filed 2022-10-27 | $12.91M derived: sum of 2 quarters · filed 2022-10-27 | $26.84M derived: sum of 3 quarters · filed 2022-10-27 | |
| 2021-06-30 | $2.48M 10-Q · filed 2022-10-27 | $16.40M derived: sum of 2 quarters · filed 2022-10-27 | ||
| 2021-03-31 | $13.93M 10-Q · filed 2022-10-27 | |||
| 2020-12-31 | $45.81M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $11.58M 10-Q · filed 2021-11-03 | $23.71M derived: sum of 2 quarters · filed 2021-11-03 | $34.30M derived: sum of 3 quarters · filed 2021-11-03 | |
| 2020-06-30 | $12.13M 10-Q · filed 2021-11-03 | $22.72M derived: sum of 2 quarters · filed 2021-11-03 | ||
| 2020-03-31 | $10.59M 10-Q · filed 2021-11-03 | |||
| 2019-12-31 | $31.10M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $7.96M 10-Q · filed 2020-11-05 | $16.31M derived: sum of 2 quarters · filed 2020-11-05 | $22.91M derived: sum of 3 quarters · filed 2020-11-05 | $27.55M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $8.35M 10-Q · filed 2020-11-05 | $14.95M derived: sum of 2 quarters · filed 2020-11-05 | $19.59M derived: sum of 3 quarters · filed 2021-02-25 | $26.25M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $6.60M 10-Q · filed 2020-11-05 | $11.24M derived: sum of 2 quarters · filed 2021-02-25 | $17.90M derived: sum of 3 quarters · filed 2021-02-25 | $21.50M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $11.30M derived: sum of 2 quarters · filed 2021-02-25 | $14.91M derived: sum of 3 quarters · filed 2021-02-25 | $18.66M 10-K · filed 2021-02-25 |
| 2018-09-30 | $6.66M 10-Q · filed 2019-11-05 | $10.27M derived: sum of 2 quarters · filed 2019-11-05 | $14.02M 10-Q · filed 2018-11-01 | $17.48M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $3.61M 10-Q · filed 2019-11-05 | $7.36M 10-Q · filed 2018-08-01 | $10.82M derived: sum of 3 quarters · filed 2020-02-25 | $14.40M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $3.75M 10-Q · filed 2019-11-05 | $7.21M derived: sum of 2 quarters · filed 2020-02-25 | $10.80M derived: sum of 3 quarters · filed 2020-02-25 | $14.54M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.04M derived: sum of 2 quarters · filed 2020-02-25 | $10.79M derived: sum of 3 quarters · filed 2020-02-25 | $13.95M 10-K · filed 2020-02-25 |
| 2017-09-30 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $7.33M derived: sum of 2 quarters · filed 2017-11-01 | $10.49M 10-Q · filed 2017-11-01 | $13.71M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $6.91M 10-Q · filed 2017-08-02 | $10.13M derived: sum of 3 quarters · filed 2019-02-27 | $13.58M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $3.16M 10-Q · filed 2017-05-03 | $6.38M derived: sum of 2 quarters · filed 2019-02-27 | $9.83M derived: sum of 3 quarters · filed 2019-02-27 | $13.17M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $6.67M derived: sum of 2 quarters · filed 2019-02-27 | $10.01M derived: sum of 3 quarters · filed 2019-02-27 | $13.60M 10-K · filed 2019-02-27 |
| 2016-09-30 | $3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $6.79M derived: sum of 2 quarters · filed 2016-11-03 | $10.38M 10-Q · filed 2016-11-03 | $14.09M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $3.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $6.93M 10-Q · filed 2016-08-04 | $10.63M derived: sum of 3 quarters · filed 2018-02-27 | $15.96M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $3.59M 10-Q · filed 2016-05-05 | $7.29M derived: sum of 2 quarters · filed 2018-02-27 | $12.62M derived: sum of 3 quarters · filed 2018-02-27 | $14.96M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $9.03M derived: sum of 2 quarters · filed 2018-02-27 | $11.37M derived: sum of 3 quarters · filed 2018-02-27 | $13.87M 10-K · filed 2018-02-27 |
| 2015-09-30 | $5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $7.67M derived: sum of 2 quarters · filed 2015-11-04 | $10.17M 10-Q · filed 2015-11-04 | $12.92M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $4.84M 10-Q · filed 2015-08-06 | $7.59M derived: sum of 3 quarters · filed 2017-03-01 | $9.51M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.50M 10-Q · filed 2015-05-08 | $5.25M derived: sum of 2 quarters · filed 2017-03-01 | $7.17M derived: sum of 3 quarters · filed 2017-03-01 | $9.57M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.67M derived: sum of 2 quarters · filed 2017-03-01 | $7.07M derived: sum of 3 quarters · filed 2017-03-01 | $9.02M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $4.32M derived: sum of 2 quarters · filed 2014-11-06 | $6.27M 10-Q · filed 2014-11-06 | $6.79M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $4.35M 10-Q · filed 2014-08-07 | $4.87M derived: sum of 3 quarters · filed 2016-02-25 | $9.07M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $1.96M 10-Q · filed 2014-05-09 | $2.47M derived: sum of 2 quarters · filed 2016-02-25 | $6.68M derived: sum of 3 quarters · filed 2016-02-25 | $11.77M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $4.72M derived: sum of 2 quarters · filed 2016-02-25 | $9.81M derived: sum of 3 quarters · filed 2016-02-25 | $14.69M 10-K · filed 2016-02-25 |
| 2013-09-30 | $4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $9.30M derived: sum of 2 quarters · filed 2013-11-07 | $14.17M 10-Q · filed 2013-11-07 | $18.90M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $5.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $9.96M 10-Q · filed 2013-08-08 | $14.69M derived: sum of 3 quarters · filed 2015-03-03 | $19.33M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $4.87M 10-Q · filed 2013-05-09 | $9.61M derived: sum of 2 quarters · filed 2015-03-03 | $14.24M derived: sum of 3 quarters · filed 2015-03-03 | $19.07M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $9.37M derived: sum of 2 quarters · filed 2015-03-03 | $14.20M derived: sum of 3 quarters · filed 2015-03-03 | $18.07M 10-K · filed 2015-03-03 |
| 2012-09-30 | $4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $9.47M derived: sum of 2 quarters · filed 2013-11-07 | $13.34M 10-Q · filed 2013-11-07 | $16.62M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $8.71M 10-Q · filed 2013-08-08 | $11.98M derived: sum of 3 quarters · filed 2014-02-27 | $14.64M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $3.87M 10-Q · filed 2013-05-09 | $7.15M derived: sum of 2 quarters · filed 2014-02-27 | $9.81M derived: sum of 3 quarters · filed 2014-02-27 | $11.63M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $5.93M derived: sum of 2 quarters · filed 2014-02-27 | $7.75M derived: sum of 3 quarters · filed 2014-02-27 | $9.29M 10-K · filed 2014-02-27 |
| 2011-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $4.48M derived: sum of 2 quarters · filed 2012-11-08 | $6.02M 10-Q · filed 2012-11-08 | $9.22M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $3.36M 10-Q · filed 2012-08-08 | $6.56M derived: sum of 3 quarters · filed 2013-02-28 | $7.32M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $1.54M 10-Q · filed 2012-05-08 | $4.74M derived: sum of 2 quarters · filed 2013-02-28 | $5.50M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.96M derived: sum of 2 quarters · filed 2013-02-28 | $5.21M 10-K · filed 2013-02-28 | |
| 2010-09-30 | $759.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $2.01M 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $1.25M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $2.86M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |